A core facility providing advanced genomic services for targeted therapeutics.
Functional Genomics Core
The Functional Genomics Core at the University of South Carolina helps scientists learn and use advanced techniques to study genes, which could lead to new treatments for patients in the future.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Carolina at Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-10936195 on NIH RePORTER |
What this research studies
The Functional Genomics Core (FGC) at the University of South Carolina offers cutting-edge genomic, transcriptomic, and epigenomic services to researchers. This facility supports investigators by providing training in Next Generation sequencing and cell line modification techniques. By collaborating with various laboratories, the FGC aims to enhance research capabilities in targeted therapeutics. Patients may benefit indirectly as the research conducted here could lead to new treatments and therapies based on genomic insights.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals with conditions that could be addressed through targeted genomic therapies.
Not a fit: Patients with conditions that are not related to genomic or targeted therapeutic approaches may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective targeted therapies for various diseases.
How similar studies have performed: Previous research in functional genomics has shown promise in advancing targeted therapies, indicating that this approach is both relevant and potentially impactful.
Where this research is happening
Columbia, United States
- University of South Carolina at Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Shtutman, Michael — University of South Carolina at Columbia
- Study coordinator: Shtutman, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.